Urticaria 12 Days After COVID-19 mRNA Booster Vaccination
- PMID: 35420647
- DOI: 10.1001/jama.2022.5247
Urticaria 12 Days After COVID-19 mRNA Booster Vaccination
Similar articles
-
Development of immediate and chronic spontaneous urticaria following mRNA COVID-19 vaccination: Tolerability of revaccination and immunological study.Ann Acad Med Singap. 2024 Jan 30;53(1):57-59. doi: 10.47102/annals-acadmedsg.2023249. Ann Acad Med Singap. 2024. PMID: 38920217 No abstract available.
-
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose.J Neurol. 2024 Jan;271(1):24-31. doi: 10.1007/s00415-023-12034-0. Epub 2023 Nov 3. J Neurol. 2024. PMID: 37922069 Free PMC article.
-
Safety and Adverse Events Among Long-term Care Residents Receiving a Third COVID-19 mRNA Vaccine Booster Dose in Quebec.JAMA Netw Open. 2022 Jul 1;5(7):e2223401. doi: 10.1001/jamanetworkopen.2022.23401. JAMA Netw Open. 2022. PMID: 35862047 Free PMC article.
-
Booster vaccination strategy: Necessity, immunization objectives, immunization strategy, and safety.J Med Virol. 2022 Jun;94(6):2369-2375. doi: 10.1002/jmv.27590. Epub 2022 Jan 19. J Med Virol. 2022. PMID: 35028946 Review.
-
Chronic urticaria: not only after COVID-19 vaccination.Curr Opin Allergy Clin Immunol. 2024 Oct 1;24(5):404-408. doi: 10.1097/ACI.0000000000001019. Epub 2024 Jul 30. Curr Opin Allergy Clin Immunol. 2024. PMID: 39079165 Review.
Cited by
-
Serious adverse events following immunization with COVID-19 vaccines in Lebanon: a retrospective analysis of the National Pharmacovigilance Database.BMC Public Health. 2024 Oct 21;24(1):2905. doi: 10.1186/s12889-024-20297-z. BMC Public Health. 2024. PMID: 39434043 Free PMC article.
-
Safety of COVID-19 Vaccines among People with History of Allergy: A European Active Surveillance Study.Vaccines (Basel). 2024 Sep 17;12(9):1059. doi: 10.3390/vaccines12091059. Vaccines (Basel). 2024. PMID: 39340089 Free PMC article.
-
New-onset chronic spontaneous urticaria post-COVID-19 vaccination-South African case series.J Allergy Clin Immunol Glob. 2023 Jul 24;2(4):100154. doi: 10.1016/j.jacig.2023.100154. eCollection 2023 Nov. J Allergy Clin Immunol Glob. 2023. PMID: 37781658 Free PMC article.
-
Tree-based data mining for safety assessment of first COVID-19 booster doses in the Vaccine Safety Datalink.Vaccine. 2023 Jan 9;41(2):460-466. doi: 10.1016/j.vaccine.2022.11.053. Epub 2022 Nov 24. Vaccine. 2023. PMID: 36481108 Free PMC article.
-
Spikevax booster and delayed urticaria: a Swiss signal with diagnostic uncertainties due to a high proportion of direct patient reports.Eur J Clin Pharmacol. 2022 Dec;78(12):2021-2022. doi: 10.1007/s00228-022-03404-0. Epub 2022 Oct 18. Eur J Clin Pharmacol. 2022. PMID: 36255481 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
